Phase Ib of L-NMMA and Pembrolizumab
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Sotio Biotech Inc.
Dana-Farber Cancer Institute
Emory University
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Kezar Life Sciences, Inc.
Pfizer
National Cancer Institute (NCI)
Hoffmann-La Roche
MacroGenics
Herlev Hospital
University of California, San Diego
Thomas Jefferson University
Shattuck Labs, Inc.
GlaxoSmithKline
Merck Sharp & Dohme LLC
BerGenBio ASA
Altor BioScience
University of Pennsylvania
Karyopharm Therapeutics Inc
Pfizer
National Cancer Institute (NCI)
Pfizer
Istari Oncology, Inc.
Pierre Fabre Medicament
National Cancer Institute (NCI)
Pfizer
Pierre Fabre Medicament
ADC Therapeutics S.A.
Parker Institute for Cancer Immunotherapy
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Pfizer
Eli Lilly and Company
Eisai Inc.
Takeda
Stanford University
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Massachusetts General Hospital
Hoffmann-La Roche
Herlev Hospital
Karyopharm Therapeutics Inc
H. Lee Moffitt Cancer Center and Research Institute
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research